Immediate Impact

4 by Nobel laureates 10 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
2022 Standout
2 intermediate papers

Works of Roger Drew being referenced

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
2001
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.
2001

Author Peers

Author Last Decade Papers Cites
Roger Drew 1026 335 589 466 47 2.0k
Martin E. Dowty 767 295 775 387 56 2.9k
Erich Gebhart 1176 132 454 156 62 2.1k
Frederick S. Philips 1092 111 582 126 72 2.6k
Michael Colvin 956 167 814 392 65 2.5k
William F. Bale 750 131 279 182 45 2.3k
Kathleen L. Berkner 1529 159 281 593 64 3.1k
Janelle M. Hoskins 788 469 1030 108 71 2.3k
Sukyung Woo 1015 117 451 204 62 2.1k
Willi Kreis 1044 88 709 171 84 2.3k
Adel A. Yunis 897 79 418 184 93 2.1k

All Works

Loading papers...

Rankless by CCL
2026